Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1628106-94-4
2. Sofpironium (bromide)
3. Bbi-4000
4. Sofpironium Bromide [usan]
5. 7b2y1932xu
6. (3r)-3-((r)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1-(2-ethoxy-2-oxoethyl)-1-methylpyrrolidin-1-ium Bromide
7. Pyrrolidinium, 3-(((2r)-2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy)-1-(2-ethoxy-2-oxoethyl)-1-methyl-, Bromide (1:1), (3r)-
8. Starbld0007908
9. Unii-7b2y1932xu
10. Chembl3707223
11. Schembl20995843
12. Sofpironium Bromide [inn]
13. Sofpironium Bromide [jan]
14. Ex-a5238
15. Sofpironium Bromide [who-dd]
16. Sofpironium Bromide (jan/usan/inn)
17. Hy-109013
18. Cs-0030511
19. D10989
20. Q27268000
21. 1-ambo-(3r)-3-(((r)-(cyclopentyl)hydroxy(phenyl) Acetyl)oxy)-1-(2-ethoxy-2-oxoethyl)-1-methylpyrrolidinium Bromide Anticholinergic
Molecular Weight | 470.4 g/mol |
---|---|
Molecular Formula | C22H32BrNO5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 9 |
Exact Mass | 469.14639 g/mol |
Monoisotopic Mass | 469.14639 g/mol |
Topological Polar Surface Area | 72.8 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 555 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31310
Submission : 2017-09-22
Status : Active
Type : II
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?